1,609 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Purchased by New Covenant Trust Company N.A.

New Covenant Trust Company N.A. bought a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,609 shares of the pharmacy operator’s stock, valued at approximately $35,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Highlander Capital Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth $26,000. Pineridge Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at approximately $26,000. Venturi Wealth Management LLC increased its holdings in shares of Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 981 shares during the last quarter. Rocky Mountain Advisers LLC acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $30,000. Finally, Quest Partners LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at approximately $30,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 2.8 %

NASDAQ:WBA traded down $0.33 during trading hours on Friday, hitting $11.48. The company’s stock had a trading volume of 14,257,085 shares, compared to its average volume of 15,724,788. The stock has a market capitalization of $9.91 billion, a P/E ratio of -1.69, a price-to-earnings-growth ratio of 0.83 and a beta of 0.72. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The stock has a fifty day moving average of $13.55 and a 200-day moving average of $17.87. Walgreens Boots Alliance, Inc. has a 52-week low of $10.69 and a 52-week high of $30.79.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). The business had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. Walgreens Boots Alliance’s revenue was up 2.8% on a year-over-year basis. During the same period last year, the business posted $1.00 EPS. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post 2.87 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 8.71%. The ex-dividend date is Wednesday, August 21st. Walgreens Boots Alliance’s payout ratio is -14.84%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on WBA shares. UBS Group cut their target price on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a research note on Wednesday, July 3rd. Royal Bank of Canada cut their price objective on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 2nd. Bank of America reaffirmed an “underperform” rating and issued a $11.00 target price (down previously from $22.00) on shares of Walgreens Boots Alliance in a research report on Friday, June 28th. TD Cowen dropped their price target on shares of Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating for the company in a research report on Monday, July 1st. Finally, Evercore ISI reduced their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a research note on Friday, June 28th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $16.86.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.